1h5u: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
[[Image:1h5u.gif|left|200px]]<br />
[[Image:1h5u.gif|left|200px]]<br /><applet load="1h5u" size="450" color="white" frame="true" align="right" spinBox="true"  
<applet load="1h5u" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="1h5u, resolution 1.76&Aring;" />
caption="1h5u, resolution 1.76&Aring;" />
'''THE 1.76 A RESOLUTION CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B COMPLEXED WITH GLUCOSE AND CP320626, A POTENTIAL ANTIDIABETIC DRUG'''<br />
'''THE 1.76 A RESOLUTION CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B COMPLEXED WITH GLUCOSE AND CP320626, A POTENTIAL ANTIDIABETIC DRUG'''<br />
Line 8: Line 7:


==About this Structure==
==About this Structure==
1H5U is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Oryctolagus_cuniculus Oryctolagus cuniculus] with GLC, CHI and PLP as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Phosphorylase Phosphorylase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.1.1 2.4.1.1] Structure known Active Sites: CHI, GLC and PLP. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1H5U OCA].  
1H5U is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Oryctolagus_cuniculus Oryctolagus cuniculus] with GLC, CHI and PLP as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Phosphorylase Phosphorylase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.1.1 2.4.1.1] Known structural/functional Sites: <scene name='pdbsite=CHI:Chi/Cp320626 Binding Site'>CHI</scene>, <scene name='pdbsite=GLC:Glc Binding Site For Chain A'>GLC</scene> and <scene name='pdbsite=PLP:Plp Binding Site For Chain A'>PLP</scene>. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1H5U OCA].  


==Reference==
==Reference==
Line 29: Line 28:
[[Category: transferase]]
[[Category: transferase]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov  5 16:30:00 2007''
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Dec 18 16:02:48 2007''

Revision as of 16:53, 18 December 2007

File:1h5u.gif


1h5u, resolution 1.76Å

Drag the structure with the mouse to rotate

THE 1.76 A RESOLUTION CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B COMPLEXED WITH GLUCOSE AND CP320626, A POTENTIAL ANTIDIABETIC DRUG

OverviewOverview

CP320626, a potential antidiabetic drug, inhibits glycogen phosphorylase, in synergism with glucose. To elucidate the structural basis of, synergistic inhibition, we determined the structure of muscle glycogen, phosphorylase b (MGPb) complexed with both glucose and CP320626 at 1.76 A, resolution, and refined to a crystallographic R value of 0.211, (R(free)=0.235). CP320626 binds at a novel allosteric site, which is some, 33 A from the catalytic site, where glucose binds. The high resolution, structure allows unambiguous definition of the conformation of the, 1-acetyl-4-hydroxy-piperidine ring supported by theoretical energy, calculations. Both CP320626 and glucose promote the less active T-state, thereby explaining their synergistic inhibition. Structural comparison of, MGPb--glucose--CP320626 complex with liver glycogen phosphorylase a (LGPa), complexed with a related compound (CP403700) show that the ligand binding, site is conserved in LGPa.

About this StructureAbout this Structure

1H5U is a Single protein structure of sequence from Oryctolagus cuniculus with GLC, CHI and PLP as ligands. Active as Phosphorylase, with EC number 2.4.1.1 Known structural/functional Sites: , and . Full crystallographic information is available from OCA.

ReferenceReference

The 1.76 A resolution crystal structure of glycogen phosphorylase B complexed with glucose, and CP320626, a potential antidiabetic drug., Oikonomakos NG, Zographos SE, Skamnaki VT, Archontis G, Bioorg Med Chem. 2002 May;10(5):1313-9. PMID:11886794

Page seeded by OCA on Tue Dec 18 16:02:48 2007

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA